NDC 51662-1480

NEXTERONE (AMIODARONE HCI)

Nexterone (amiodarone Hci)

NEXTERONE (AMIODARONE HCI) is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Amiodarone Hydrochloride.

Product ID51662-1480_9d4d66f7-fa15-e832-e053-2a95a90a8b62
NDC51662-1480
Product TypeHuman Prescription Drug
Proprietary NameNEXTERONE (AMIODARONE HCI)
Generic NameNexterone (amiodarone Hci)
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-01-29
Marketing CategoryNDA /
Application NumberNDA022325
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameAMIODARONE HYDROCHLORIDE
Active Ingredient Strength2 mg/mL
Pharm ClassesCytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Antiarrhythmic [EPC],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 51662-1480-1

1 BAG in 1 CARTON (51662-1480-1) > 100 mL in 1 BAG
Marketing Start Date2020-01-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NEXTERONE (AMIODARONE HCI)" or generic name "Nexterone (amiodarone Hci)"

NDCBrand NameGeneric Name
51662-1480NEXTERONE (AMIODARONE HCI)NEXTERONE (AMIODARONE HCI)
51662-1481NEXTERONE (AMIODARONE HCI)NEXTERONE (AMIODARONE HCI)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.